Last reviewed · How we verify
Oxycodone and Midazolam
At a glance
| Generic name | Oxycodone and Midazolam |
|---|---|
| Sponsor | Food and Drug Administration (FDA) |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery (NA)
- ACU_Knee: Role of Acupuncture in Knee Prosthetic Surgery (NA)
- The Effect of Superficial Parasternal Intercostal Plane Block on Pulmonary Function Tests After Cardiac Surgery (NA)
- Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation (PHASE1)
- Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
- Opioid Free Anesthesia in Thoracic Surgery (NA)
- Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy (PHASE4)
- Pharmacotherapy Personalization of Cancer Patients
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oxycodone and Midazolam CI brief — competitive landscape report
- Oxycodone and Midazolam updates RSS · CI watch RSS
- Food and Drug Administration (FDA) portfolio CI